Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for normal, poor and sub optimal responders?
Letrozole co-administration during OS for IVF increases the number of retrieved oocytes, zygotes, and TQE in poor and sub-optimal responders but not in normal responders.
Authors
- Ettie Maman (ORCID: https://orcid.org/0000-0002-7534-6650)
- Ravit Nahum
- Oshrit Lebovitz (ORCID: https://orcid.org/0000-0003-1171-110X)
- Adva Aizer (ORCID: https://orcid.org/0000-0003-0820-8079)
- Jigal Haas (ORCID: https://orcid.org/0000-0001-5274-7358)
- Lilach Marom Haham (ORCID: https://orcid.org/0000-0001-8913-9495)
- Raoul Orvieto (ORCID: https://orcid.org/0000-0002-0865-1196)
- Moran Shapira (ORCID: https://orcid.org/0000-0002-5031-9015)
- Merav Noach-Hirsh
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
Publication Details
- Journal
- Gynecologic and Obstetric Investigation
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1159/000546147
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00